ABCL icon

AbCellera Biologics
ABCL

Overview Fund Activity

130 hedge funds and large institutions have $1.1B invested in AbCellera Biologics in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.

Holders
130
Holders Change
+6
Holders Change %
+4.84%
% of All Funds
2.06%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
28
Increased
41
Reduced
36
Closed
21
Calls
$27.1M
Puts
$8.04M
Net Calls
+$19.1M
Net Calls Change
-$5.55M

Top Buyers

1
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$108M
2
Lazard Asset Management
2
Lazard Asset Management
New York
$31.1M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$25.5M
4
Millennium Management
4
Millennium Management
New York
$14.6M
5
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$6.12M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$25.6M
2
Capital World Investors
2
Capital World Investors
California
$178M
3
Swedbank
3
Swedbank
Sweden
$0
4
SM
4
SB Management
United Arab Emirates
$75.7M
5
CII
5
Capital International Inc
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JAM
151
JCIC Asset Management
Ontario, Canada
$0 25 – –
CFGS
152
Concourse Financial Group Securities
Alabama
– – – –
PCM
153
Prelude Capital Management
New York
– – – –
SCM
154
Suvretta Capital Management
New York
– – – –
HT
155
HAP Trading
New York
– – – –
3 4 5 6
7